Delivery Order SPE2DB22D1002-SPE2DB25FLCX6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency awarded a $2,366.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract is unset-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through federal medical procurement channels to support military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a $5,734.19 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, representing one of many pharmaceutical products AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a $6,044.85 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a firm fixed price ceiling value of $1,201.20. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a branded pharmaceutical product used in diabetes management, representing one of many...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a contract value of $3,903.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity, a diabetes...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLCX6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $10,429.78 with a firm fixed price structure. This delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor and is scheduled for completion by June 3, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly procured by the Defense Health Agency to support military healthcare programs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies to military healthcare systems worldwide. The company's substantial federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for the Department of Defense and affiliated federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 6/2/25 |